Amlodipine/atorvastatin

Amlodipine/atorvastatin

Combination of
Amlodipine	Calcium channel blocker
Atorvastatin	Statin
Clinical data
Trade names	Caduet, Envacar, others
AHFS/Drugs.com	Professional Drug Facts
License data	US  DailyMed:  Caduet
Pregnancy category	AU:D Contraindicated
Routes of administration	By mouth
ATC code	C10BX03 ( WHO )
Legal status
Legal status	AU: S4 (Prescription only) US: ℞-only In general: ℞ (Prescription only)
Identifiers
CAS Number	858659-02-6
PubChem CID	9811759
ChemSpider	7987512  Y
KEGG	D08488
CompTox Dashboard (EPA)	DTXSID101027010
(verify)

Amlodipine/atorvastatin, sold under the brand name Caduet among others, is a fixed-dose combination medication for the treatment of high cholesterol and high blood pressure. It contains a statin and a calcium channel blocker. ^{[1] [2]}

Society and culture

Brand names

Amlodipine/atorvastatin is marketed under the brand name Caduet in the United States, Australia, and Russia, and Envacar in the Philippines. ^{[3] [4]}

In some countries Caduet is marketed by Viatris after Upjohn was spun off from Pfizer. ^{[5] [6] [7]}

References

1. Curran MP (2010). "Amlodipine/Atorvastatin". Drugs. 70 (2). Springer Science+Business Media: 191–213. doi:10.2165/11204420-000000000-00000. ISSN   0012-6667. PMID   20108992. S2CID   209144335.
2. Devabhaktuni M, Bangalore S (2009). "Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives". Vascular Health and Risk Management. 5 (1): 377–87. doi: 10.2147/vhrm.s3339 . PMC   2686256 . PMID   19475775.
3. "Caduet - Drugs.com". Archived from the original on 19 June 2014.
4. "Envacar - Drugs.com". Archived from the original on 20 June 2014.
5. "Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan". Pfizer. 16 November 2020. Retrieved 17 June 2024– via Business Wire.
6. "Caduet". Pfizer. Retrieved 17 June 2024.
7. "Brands". Viatris. 16 November 2020. Retrieved 17 June 2024.